Nearly a year after Labcorp struck a deal for certain diagnostics assets from BioReference Health, the lab-testing giant is ...

Nearly a year after Labcorp struck a deal for certain diagnostics assets from BioReference Health, the lab-testing giant is back to buy the firm’s cancer tests. Labcorp is paying $192.5 million ...

Labcorp will acquire BioReference Health's oncology diagnostics operations as the lab company works to expand in high-growth ...

Labcorp (LH) and OPKO Health (OPK) announced earlier on Tuesday that they have entered into an agreement for Labcorp to acquire select assets of BioReference Health, a wholly owned subsidiary of ...

More Details on Labcorp’s Acquisition Deal Labcorp will acquire OPKO’s BioReference Health's laboratory testing businesses focused on oncology and oncology-related clinical testing services ...

Labcorp continues string of acquisitions with a deal adding BioReference oncology services in $225 million deal. Burlington-based Labcorp is investing almost a quarter of a billion dollars to add ...

Labcorp (LH) and OPKO Health (OPK) announced earlier on Tuesday that they have entered into an agreement for Labcorp to acquire select assets ...

Labcorp Holdings has signed a deal to buy certain assets of OPKO Health's BioReference Health unit for up to $225 million. Labcorp on Tuesday said it will pay $192.5 million at closing for ...

LH inks new agreement to acquire BioReference Health's oncology and related clinical testing services businesses.

Labcorp will acquire BioReference Health's laboratory testing businesses focused on oncology and oncology-related clinical testing services across the United States. This transaction includes certain ...